171 related articles for article (PubMed ID: 29623978)
1. In vitro elucidation of the role of pericellular matrix in metastatic extravasation and invasion of breast carcinoma cells.
Brett ME; Bomberger HE; Doak GR; Price MA; McCarthy JB; Wood DK
Integr Biol (Camb); 2018 Apr; 10(4):242-252. PubMed ID: 29623978
[TBL] [Abstract][Full Text] [Related]
2. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides.
Ween MP; Hummitzsch K; Rodgers RJ; Oehler MK; Ricciardelli C
Clin Exp Metastasis; 2011 Feb; 28(2):113-25. PubMed ID: 21153687
[TBL] [Abstract][Full Text] [Related]
3. Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility.
Ricciardelli C; Russell DL; Ween MP; Mayne K; Suwiwat S; Byers S; Marshall VR; Tilley WD; Horsfall DJ
J Biol Chem; 2007 Apr; 282(14):10814-25. PubMed ID: 17293599
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan mediates adhesion of metastatic colon carcinoma cells.
Laurich C; Wheeler MA; Iida J; Neudauer CL; McCarthy JB; Bullard KM
J Surg Res; 2004 Nov; 122(1):70-4. PubMed ID: 15522317
[TBL] [Abstract][Full Text] [Related]
6. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment.
Turley EA; Wood DK; McCarthy JB
Cancer Res; 2016 May; 76(9):2507-12. PubMed ID: 27197262
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
[TBL] [Abstract][Full Text] [Related]
9. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells.
Evanko SP; Angello JC; Wight TN
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1004-13. PubMed ID: 10195929
[TBL] [Abstract][Full Text] [Related]
10. A microfluidic platform for modeling metastatic cancer cell matrix invasion.
Blaha L; Zhang C; Cabodi M; Wong JY
Biofabrication; 2017 Sep; 9(4):045001. PubMed ID: 28812983
[TBL] [Abstract][Full Text] [Related]
11. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
[TBL] [Abstract][Full Text] [Related]
12. CD44 attenuates metastatic invasion during breast cancer progression.
Lopez JI; Camenisch TD; Stevens MV; Sands BJ; McDonald J; Schroeder JA
Cancer Res; 2005 Aug; 65(15):6755-63. PubMed ID: 16061657
[TBL] [Abstract][Full Text] [Related]
13. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells.
Simpson MA; Reiland J; Burger SR; Furcht LT; Spicer AP; Oegema TR; McCarthy JB
J Biol Chem; 2001 May; 276(21):17949-57. PubMed ID: 11278609
[TBL] [Abstract][Full Text] [Related]
15. Particle Exclusion Assay: A Tool for Measuring Hyaluronan Pericellular Matrix.
Parnigoni A; Moretto P; Rovera S; Viola M; Karousou E; Passi A; Vigetti D
Methods Mol Biol; 2023; 2619():53-60. PubMed ID: 36662461
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan.
Twarock S; Reichert C; Peters U; Gorski DJ; Röck K; Fischer JW
Int J Cancer; 2017 Aug; 141(4):791-804. PubMed ID: 28493326
[TBL] [Abstract][Full Text] [Related]
18. The cancer glycocalyx mediates intravascular adhesion and extravasation during metastatic dissemination.
Offeddu GS; Hajal C; Foley CR; Wan Z; Ibrahim L; Coughlin MF; Kamm RD
Commun Biol; 2021 Feb; 4(1):255. PubMed ID: 33637851
[TBL] [Abstract][Full Text] [Related]
19. Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells.
Gialeli Ch; Viola M; Barbouri D; Kletsas D; Passi A; Karamanos NK
Biochim Biophys Acta; 2014 Aug; 1840(8):2549-59. PubMed ID: 24582970
[TBL] [Abstract][Full Text] [Related]
20. Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Veiseh M; Kwon DH; Borowsky AD; Tolg C; Leong HS; Lewis JD; Turley EA; Bissell MJ
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):E1731-9. PubMed ID: 24733940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
